{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 48,
  "pageCount": 239,
  "prevPage": 47,
  "nextPage": 49,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses strong, aggressive language to discredit the company's product claims and growth strategy.",
  "elementsJson": [
    "headline_text",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/48",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-48",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The centerpiece of Nevro’s turnaround plan – the Omnia stimulator launched in Nov 2019 – is a Hail Mary and colossal flop.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33a-3c1b0bd8b21f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.88,
        "x": 0.06,
        "y": 0.14
      },
      "kind": "list",
      "text": "The centerpiece of Nevro's turnaround plan – the Omnia stimulator launched in Nov 2019 – is a Hail Mary and colossal flop (cont'd)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5bb91896-7839-4089-939b-a085384ef713",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.06,
        "y": 0.65
      },
      "kind": "list",
      "text": "Painful diabetic neuropathy (PDN) and other new indications that Nevro has recently begun to hype are as unlikely to restart growth or a turnaround as its failed Omnia launch.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66f1db3f-ee86-4abf-b45c-691cade0e8a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Omnia is a joke I think to most doctors...even the doctors that were loyal Nevro users.\" — KOL; \"a marketing move\" — Nevro implanter; \"an attempt to save market share with a beleaguered cohort of doctors that are sick of explanting the device.\" — Former Nevro user; \"window dressing with Grossman\" — Former Nevro executives and sales reps; \"just re-packaging of an old product,\" — Former Nevro executives and sales reps; \"nobody’s going to buy Omnia\" — Former Nevro executives and sales reps; \"a lie.\" — KOL; \"it’s impossible to capture\" — KOL; \"so stupid\" — KOL; \"just dopey.\" — KOL; \"value to Wall Street and no one else.\" — KOL; \"putting lipstick on a pig,\" — KOL; \"smoke and mirrors\" — KOL; \"trying to hoodwink,\" — KOL",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33a-400401689a5f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f28226d-67c2-4dec-b1db-f77d4ca016b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.18,
        "x": 0.06,
        "y": 0.1
      },
      "kind": "title",
      "text": "2. Summary of key findings",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3cc819a1-d673-49ab-9d14-94b447d38a01",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "5fecc442-5c7e-470e-b7ec-1e70c113b903",
      "evidence": "The slide explicitly labels company claims as 'fraudulent narrative', 'a lie', and 'misleading'.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 50,
      "from": 21,
      "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": "overcoming-monster-the-struggle",
      "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}